NCT04983823View on ClinicalTrials.gov

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

NARecruitingINTERVENTIONAL
Enrollment

820

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

July 30, 2025

Study Completion Date

December 30, 2025

Conditions
Heart Failure
Interventions
OTHER

Heart Failure intervention (Cardiac COVID Disease Management Plan (CC-DMP)

A clinical review to ensure optimal risk factor control and cardioprotection along with exercise intervention.

OTHER

Usual care

This will be provided by participants' usual healthcare professional(s).

Trial Locations (1)

3004

RECRUITING

Baker Heart and Diabetes Institute, Melbourne

All Listed Sponsors
lead

Baker Heart and Diabetes Institute

OTHER